453 related articles for article (PubMed ID: 35746659)
21. Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician.
Chiappini E; Licari A; Motisi MA; Manti S; Marseglia GL; Galli L; Lionetti P
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):92-95. PubMed ID: 33236437
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.
Maghool F; Valiani A; Safari T; Emami MH; Mohammadzadeh S
Scand J Immunol; 2021 Apr; 93(4):e12999. PubMed ID: 33190306
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota Status in COVID-19: An Unrecognized Player?
Donati Zeppa S; Agostini D; Piccoli G; Stocchi V; Sestili P
Front Cell Infect Microbiol; 2020; 10():576551. PubMed ID: 33324572
[TBL] [Abstract][Full Text] [Related]
24. Impact of COVID-19 on the Intestinal Microbiome.
Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
[TBL] [Abstract][Full Text] [Related]
25. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
Wang M; Zhang Y; Li C; Chang W; Zhang L
Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
[TBL] [Abstract][Full Text] [Related]
26. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
27. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
Grenga L; Pible O; Miotello G; Culotta K; Ruat S; Roncato MA; Gas F; Bellanger L; Claret PG; Dunyach-Remy C; Laureillard D; Sotto A; Lavigne JP; Armengaud J
Environ Microbiol; 2022 Sep; 24(9):4299-4316. PubMed ID: 35506300
[TBL] [Abstract][Full Text] [Related]
28. [Diseases of the gastrointestinal tract in the context of COVID-19 infection: present and future challenges: A review].
Maev IV; Osadchuk MA
Ter Arkh; 2023 Sep; 95(7):586-590. PubMed ID: 38159010
[TBL] [Abstract][Full Text] [Related]
29. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.
Levy E; Stintzi A; Cohen A; Desjardins Y; Marette A; Spahis S
Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G99-G112. PubMed ID: 34009033
[TBL] [Abstract][Full Text] [Related]
30. COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis?
Chaves Andrade M; Souza de Faria R; Avelino Mota Nobre S
Med Hypotheses; 2020 Nov; 144():110206. PubMed ID: 33254513
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies.
Liu S; Zhao Y; Feng X; Xu H
Crit Rev Food Sci Nutr; 2023 Nov; 63(33):12578-12596. PubMed ID: 35894645
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal mucosal immunity and COVID-19.
Velikova T; Snegarova V; Kukov A; Batselova H; Mihova A; Nakov R
World J Gastroenterol; 2021 Aug; 27(30):5047-5059. PubMed ID: 34497434
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
[TBL] [Abstract][Full Text] [Related]
35. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
[TBL] [Abstract][Full Text] [Related]
36. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
[TBL] [Abstract][Full Text] [Related]
37. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
[TBL] [Abstract][Full Text] [Related]
38. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
Brooks EF; Bhatt AS
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Chattopadhyay I; Shankar EM
Front Cell Infect Microbiol; 2021; 11():590874. PubMed ID: 33791231
[TBL] [Abstract][Full Text] [Related]
40. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.
Tieu V; Tibi S; Ling J
Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
